Amgen’s fair value target has seen a modest increase, now set at $318.51 compared to its previous level of $311.88. Recent ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Abstract: Deep polyp segmentation methods have shown remarkable potential in boosting diagnostic efficiency. Nevertheless, these methods rely on sufficient pixel-wise annotated data, which is ...

Abstract: Accurate and real-time segmentation of polyps in digestive endoscopy is critical for improving the diagnosis and treatment of gastrointestinal diseases. Although Transformer-based models ...